Zurueck zur Suche

Reporte zur Charge U018309

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

41Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
OH 6 WA 6 OR 3 CA 3 AZ 3 VA 2 MI 2 AL 2 FL 2 MA 1 WV 1 NY 1

VAERS 2311501

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge u018309

moderat
Staat
MA
Alter
94,0
Geschlecht
F
Eingang
07.06.2022
Impfdatum
03.06.2022
Beginn
03.06.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Paraesthesia

Symptomtext

, Additional Details: Patient was experiencing tingling down both her legs

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2098841

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

moderat
Staat
WA
Alter
58,0
Geschlecht
F
Eingang
09.02.2022
Impfdatum
11.01.2022
Beginn
12.01.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Chills Fatigue Injected limb mobility decreased Limb discomfort Muscular weakness Pain in extremity Peripheral coldness

Symptomtext

I day post vaccinations Right arm hurt so badly that pt was unable to lift it/use it functionally and I started to have chills. By evening, pt stated she was under two blankets, shivering. hands were extremely cold as if they were in ice water. This lasted ~ 24 hours with another 24 hours to follow feeling fatigued with lack of left upper extremity usage

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injected limb mobility decreased
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Hashimoto's thyroiditis (Chronic) Hypercholesteremia
Andere Medikamente
diazePAM levothyroxine rizatriptan rosuvastatin
Allergien
No Known Allergies
Vorherige Impfungen
similar response reported by patient post COVID vaccinations 12/23/2020 and 1/12/2021

VAERS 2074563

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

moderat
Staat
VA
Alter
63,0
Geschlecht
F
Eingang
09.02.2022
Impfdatum
21.01.2022
Beginn
22.01.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Discomfort Headache Hyperhidrosis Insomnia Lacrimation increased Mobility decreased Monoplegia Nausea Pain in extremity Movement disorder Muscular weakness Screaming

Symptomtext

Patient states she developed weakness in the right arm/ Unable to move

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mobility decreased
Hospital-Tage
-
Labordaten
Patient referred to Neurology for further testing
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Venlafaxine 150 mg, Famotidine 20 mg, Biotin 5mg, Multivitamin, Simvastatin 20 mg, Nemenda XR 28mg
Allergien
Bee stings, Propofol, sulfa drugs
Vorherige Impfungen
-

VAERS 1992367

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

moderat
Staat
GA
Alter
63,0
Geschlecht
F
Eingang
13.01.2022
Impfdatum
29.12.2021
Beginn
29.12.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Immediate post-injection reaction Injection site pain Mobility decreased Musculoskeletal stiffness Pain Injected limb mobility decreased Injection site erythema Pain in extremity Peripheral swelling

Symptomtext

Immediate pain at injection site that increased in intensity to a severe level of 10 on a pain scale of 1-10. that level of pain lasted for 12 hours. The arm swelled to three times it's size and so had stiffness and loss of mobility without pain. That lasted four days. The pain persisted on a pain scale of 5 at the injection site continually to this date of 1/1/2022. The mobility of the arm causes pain in the arm to increase and spreads throughout the arm, not just the injection site. that pain scale is about a 5-7. There was no treatment other than ice the arm due to Pharmacist stating her corporate office will call me to manage this situation. I had one phone call that left a voicemail. I called back several times. I never received a call back for TWO WEEKS. I finally left a strong message and was called back on that day, January 9, 2022. I was told in Risk Management, that they do nothing for vaccine reactions and to fill out a report to VAERS. I had called my Clinic and went to see my doctor on January 9th.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injected limb mobility decreased
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Asthma
Andere Medikamente
Amlodipine 5 mg; Lisinopril 20 mg; Famotidine 40 mg; Fluticasone Propionate/Salmeterol Discus powder 100/50; Iron 45 mg
Allergien
Tigan; Compazine; Prozac
Vorherige Impfungen
-

VAERS 2019694

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

moderat
Staat
MI
Alter
73,0
Geschlecht
F
Eingang
09.01.2022
Impfdatum
29.12.2021
Beginn
29.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Arthralgia Condition aggravated Erythema Pain in extremity Peripheral swelling

Symptomtext

soreness progressed through the day. red and swollen, no itching. by 2nd day very painful, shoulder to elbow, red and swollen inner half arm shoulder to elbow. lasted a week before total cleared up

Weitere VAERSDATA-Felder
Praegender Schweregrund
Condition aggravated
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
no
Vorgeschichte
non
Andere Medikamente
armor thyroid; Vitamin D3, C, B-12
Allergien
sulfa
Vorherige Impfungen
red swollen arm, age 65, 11/2013, pneumococcal(90723)

VAERS 1868342

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

moderat
Staat
SD
Alter
62,0
Geschlecht
M
Eingang
14.11.2021
Impfdatum
08.11.2021
Beginn
08.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Aphasia Asthenia Computerised tomogram head normal Constipation Dyspnoea Ear pain Electrocardiogram Epigastric discomfort Fatigue Feeling cold Full blood count Heart rate increased Malaise Metabolic function test Nausea Pain in extremity Sleep disorder Thirst

Symptomtext

Feeling unwell, ill, epigastric discomfort, trouble speaking Per pt: My body reaction to the 3 shots reached the peak after ~12 hours at 9:50 pm, with symptoms including nausea, shortage of breath, rapid heart rate, feeling cold, and shacking of my hands and whole body so that I could not speak to ask for help and was feeling dying A series of symptoms occurred in the past two days, including fatigue, constipation, ear pain, thirsty, weak and pain with both arms. I could not sleep until early morning the last night because of continuous ear pain even I took a pill of Tylenol.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
ER visit on 11/8/21 - CBC, CMP, Troponin, EKG, head CT unremarkalbe
Aktuelle Erkrankungen
none
Vorgeschichte
type 2 diabetes, hyperlipidemia
Andere Medikamente
Atorvastatin 20 mg
Allergien
Sulfa drugs and tetracycline
Vorherige Impfungen
-

VAERS 1798941

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

moderat
Staat
OR
Alter
47,0
Geschlecht
F
Eingang
19.10.2021
Impfdatum
19.10.2021
Beginn
19.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Hypoaesthesia Injected limb mobility decreased Pain Product administered at inappropriate site

Symptomtext

I don?t know which vaccine was given first, but both were in left arm. The first one, the MA injected into my shoulder. It immediately felt like a cortisol injection into the joint because years ago I had a right shoulder injection. She then administered the second one into the upper deltoid. Once ai saw where she placed the bandaids, I knew she gave it in the wrong place. She did not palpate the landmarks or even look for the deltoid. She was a new MA and had a trainer with her. He didn?t say anything either or correct her. Right before she gave my my shots, she gave my 8 year old 2 shots and was going in and out several times with the needle. The trainer had to tell her she was done. My left shoulder began really aching and I felt numbness in the outer part of my hand starting about 20 minutes after. I asked the MA to call the provider back in. The provider assessed the site and looked at where it was given and apologized saying it can happen. It has gotten worse throughout the day. I cannot raise my left arm without sever pain and this is only the same day.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injected limb mobility decreased
Hospital-Tage
-
Labordaten
None yet
Aktuelle Erkrankungen
None
Vorgeschichte
Hypothyroidism, heart murmur, depression, hormone replacement therapy, POTS.
Andere Medikamente
Sertraline, lisinopril, metoprolol, alprazolam, levothyroxine, estradiol patch,
Allergien
Prochlorperazine, compazine, wellbutrin
Vorherige Impfungen
Influenza 2015 arm swelling, redness

VAERS 2496851

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge u018309

mild
Staat
-
Alter
72,0
Geschlecht
F
Eingang
02.11.2022
Impfdatum
01.11.2022
Beginn
01.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Neck pain Pain in extremity

Symptomtext

Patient stated she had pain in shoulder, arm and neck after vaccination.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Ibuprofen and Tylenol
Allergien
-
Vorherige Impfungen
-

VAERS 2493510

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

mild
Staat
CA
Alter
18,0
Geschlecht
F
Eingang
30.10.2022
Impfdatum
20.10.2022
Beginn
22.10.2022
Tage bis Beginn
2,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Erythema Injection site erythema Injection site warmth Pain Peripheral swelling Pyrexia

Symptomtext

R arm swelling, redness, pain, tactile fever on 10/22. Took Ibuprofen, Dayquil, and Nyquil. Pt seen on 10/25 for follow up visit regarding test results from visit on 10/17 for evaluation of urticaria/facial edema and mentioned having received the PPSV23 vaccine on 10/20 with reaction beginning 10/22, slowly improving with Ibuprofen, Dayquil, Nyquil. Exam of RUE on 10/25: large area of erythema, mild warmth, mild ttp, no edema, no abcess, no cellulitis, able to raise RUE above her head, normal ROM R elbow

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
Recurrent urticaria and Facial edema and history of mild intermittent asthma
Vorgeschichte
none other than that mentioned above
Andere Medikamente
ALBUTEROL BCP CETIRIZINE HCL 10 MG TABS; ONE TABLET Q AM DIPHENHYDRAMINE HCL 25 MG CAPS; 1 CAPSULE (25 MG) ORALLY DAILY AT BEDTIME AS NEEDED FOR HIVES/SWELLING FAMOTIDINE 20 MG TABS; 1 TABLET (20 MG) ORALLY DAILY 30 MINUTES BEFORE MEAL
Allergien
NKDA or food allergies. Was seen on 10/17 for Recurrent urticaria and Facial edema
Vorherige Impfungen
-

VAERS 2455265

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

mild
Staat
AZ
Alter
66,0
Geschlecht
F
Eingang
22.09.2022
Impfdatum
20.09.2022
Beginn
21.09.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Erythema

Symptomtext

Pt. received the Pneumovax on 9-20-22 (Tuesday) in the left deltoid. Pt. came by the pharmacy the next evening and presented with redness and pain in the left arm around the elbow. Pt. stated that other then the pain in her elbow, she was fine. She was counseled to follow up with a doctor the next day. Pt. at the present time does not have a PCP.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Hypertension, High Cholesterol, Heart burn
Andere Medikamente
None
Allergien
Menthol
Vorherige Impfungen
-

VAERS 2436286

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

mild
Staat
AZ
Alter
65,0
Geschlecht
F
Eingang
09.09.2022
Impfdatum
06.09.2022
Beginn
06.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Chills Decreased appetite Ear pain Erythema Headache Peripheral swelling Rash Skin irritation

Symptomtext

After patient left office arm were the vaccines were given started to turn red with irritation. Next day patient experienced headaches, chills, ear aches, joint pain, and loss of appetite. Rash grew to cover most of the upper arm with swelling.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
Patient instructed on 09/09/22 to take Ibuprofen or Tylenol for the pain. Also to take Benadryl every 4 hours as needed.
Aktuelle Erkrankungen
None
Vorgeschichte
Hyperlipidemia
Andere Medikamente
Amitriptyline, Elmiron, Estring, Fluoxetine, Meloxicam, Zolpidem
Allergien
Chlorhexidine, Hydrocodone
Vorherige Impfungen
-

VAERS 2379316

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

mild
Staat
KS
Alter
15,0
Geschlecht
F
Eingang
22.07.2022
Impfdatum
20.07.2022
Beginn
20.07.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pain Injection site swelling Injection site warmth Vaccination error

Symptomtext

Pneumovax23 was given in error on 7/20/2022. Once it was caught patient and parent were immediately notified. Advised to watch out for signs of local/systemic reaction and to call with any updates. Checked on pt on 7/21, did not report any reaction. On 7/22 pt presented with a small red area below injection site. The area was slightly raised and warm to the touch. Pt reported pain in the area but it had decreased since onset. Encouraged to follow up with a primary care provider if redness/pain increased or did not resolve.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
Sinus congestion/head cold.
Vorgeschichte
Prone to pneumonia infections.
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2320977

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

mild
Staat
AL
Alter
74,0
Geschlecht
F
Eingang
15.06.2022
Impfdatum
10.06.2022
Beginn
10.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Pain in extremity Peripheral swelling

Symptomtext

Patient received vaccine and had arm swelling and pain for a few days.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2092860

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge u018309

mild
Staat
AL
Alter
73,0
Geschlecht
M
Eingang
16.03.2022
Impfdatum
04.02.2022
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Erythema Infection Pain in extremity Swelling Feeling hot Musculoskeletal disorder Musculoskeletal stiffness Vaccination site discolouration Vaccination site pain

Symptomtext

He is complaining that the right arm where he received the shot is sore, and turned dark red.; He is complaining that the right arm where he received the shot is sore, and turned dark red.; His right arm also, feels hot, stiff, and tight; His right arm also, feels hot, stiff, and tight; His right arm also, feels hot, stiff, and tight; This is a spontaneous report received from a contactable Consumer. The reporter is the patient. A 72 year-old male patient received pneumococcal 20-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 20), administration date 04Feb2022 (Batch/Lot number: unknown) at the age of 73 years as unknown, single for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE DISCOLOURATION (non-serious), VACCINATION SITE PAIN (non-serious), outcome "unknown" and all described as "He is complaining that the right arm where he received the shot is sore, and turned dark red."; FEELING HOT (non-serious), MUSCULOSKELETAL STIFFNESS (non-serious), MUSCULOSKELETAL DISORDER (non-serious), outcome "unknown" and all described as "His right arm also, feels hot, stiff, and tight". Additional information: patient had the shot on Friday afternoon. He was complaining that the right arm where he received the shot was sore, and turned dark red. He put marks around it and it has spread around his whole arm, almost like an old fashion measles shot. His right arm also, feels hot, stiff, and tight. Patient was told that it would be sore by the pharmacist. Stated that on Saturday that the area was sore and turned red so he put marks to see if it got bigger. Stated that it spread all the way across his arm. Stated that the injection site was red and dark red like an old fashioned small pox vaccine is. Stated that is what it looked like. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2110181

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

mild
Staat
MN
Alter
57,0
Geschlecht
M
Eingang
14.02.2022
Impfdatum
11.02.2022
Beginn
13.02.2022
Tage bis Beginn
2,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Oxygen saturation decreased Pyrexia

Symptomtext

Onset of fever 2/13/2022. O2 SATs in the low-mid 80's beginning 2/14/2022. Treatment included: Oxygen via NC and hospital admission.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Cerebral palsy
Andere Medikamente
-
Allergien
NKA
Vorherige Impfungen
-

VAERS 2034058

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

mild
Staat
OH
Alter
70,0
Geschlecht
F
Eingang
14.01.2022
Impfdatum
14.12.2021
Beginn
14.12.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Limb discomfort Muscular weakness Pain in extremity

Symptomtext

severe pain in her whole arm, where she have to pick up her arm to use it; arm "felt heavy"; This spontaneous report as received from a medical assistant refers to a 70-year-old female patient. The patient had no known allergies. No information regarding the patient's pertinent medical history and concomitant therapies was provided. On 14-DEC-2021, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) syringe, lot # U018309, expiry date 08-JAN-2023, 0.5 milliliter, intramuscularly in the left arm for prophylaxis (reported as immunization). In the evening of 14-DEC-2021, after the administration of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23), the patient started to experience severe pain in her whole arm, where she had to pick up her arm to use it (pain in extremity), and her arm also "felt heavy" (limb discomfort). No treatment was given for the adverse events. The patient did not seek a medical attention in regards to the events. The outcome of pain in extremity and limb discomfort was unknown. The relatedness between the events of pain in extremity and limb discomfort and pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was not reported. This is one of several reports received from the same reporter. ; Sender's Comments: US-009507513-2112USA010039: US-009507513-2112USA010305: US-009507513-2112USA010181:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2031522

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

mild
Staat
NJ
Alter
24,0
Geschlecht
F
Eingang
13.01.2022
Impfdatum
05.01.2022
Beginn
05.01.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Arthralgia Erythema Injection site bruising Joint range of motion decreased Musculoskeletal stiffness Tenderness

Symptomtext

Pt c/o redness approx 5in x 3 inches on left delt. +tenderness. very sore/tender to the touch. some stiffness/decreased ROM r/t soreness. Symptoms began a few hours after injection and worsened gradually. Seen in urgent care office 1/8/22. Pt was given an injection of 10 mg dexamethasone in office on 1/8/22. Of note, area of bruising in center of redness is in an appropriate place on deltoid, do not suspect that improper (too high) injection technique is the cause.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
-
Vorgeschichte
ADHD, depression, chronic migraine, sleep disorder
Andere Medikamente
nurtec, botox injection for migraine, focalin, zofran, mometazone, matriptan, iron, coQ10, B12, magnesium, birth control pill
Allergien
imitrex, macrobid
Vorherige Impfungen
-

VAERS 2030880

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

mild
Staat
OH
Alter
62,0
Geschlecht
F
Eingang
13.01.2022
Impfdatum
20.12.2021
Beginn
20.12.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dizziness Feeling cold Hypoaesthesia Muscular weakness Nausea Pain in extremity Vomiting

Symptomtext

This spontaneous report as received from a medical assistant refers to a 62-year-old female patient. The patient's current conditions included drug reactions/allergies to cephalexin (KEFLEX) and nitrofurantoin (MACROBID). Her pertinent medical history and concomitant medications were not reported. On 20-DEC-2021, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) syringe, lot # U018309, expiry date 08-JAN-2023, 0.5 milliliter, intramuscularly in the left arm for prophylaxis (reported as immunization). On 20-DEC-2021, the night of the administration of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23), the patient experienced pain and weakness in her left arm, numbness, nausea, vomiting, lightheadedness, and "her arm had got cold". On 28-DEC-2021, the patient came to the physician's office and reported that she was still experiencing the adverse events that she initially had and the only change was the pain was only at the top half of her arm. No treatment was given for the adverse events. The outcome of the events was reported as not recovered. The relatedness between the events and pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was not reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-2112USA010039: US-009507513-2112USA010311: US-009507513-2112USA010181.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Allergic reaction to antibiotics
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2000138

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

mild
Staat
OH
Alter
57,0
Geschlecht
F
Eingang
03.01.2022
Impfdatum
15.12.2021
Beginn
17.12.2021
Tage bis Beginn
2,0
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Limb discomfort Malaise Nausea Pain in extremity

Symptomtext

severe pain done her arm; arm felt heavy; nausea; not feeling good; This spontaneous report was received from a medical assistant and refers to a 57-year-old female. The patient's medical history and concurrent conditions were not reported. Concomitant therapies were not reported. On 15-DEC-2021, the patient started therapy with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) pre-filled syringe injection, lot #U018309, expiration date: 08-JAN-2023, administered intramuscularly into the right arm for immunisation (strength was not provided). On 17-DEC-2021, the patient experienced severe pain done her arm (pain in extremity), her arm felt heavy (limb discomfort ), nausea (nausea) and not feeling good (malaise). The patient did not seek medical attention. No treatment was given for the events. The outcome of aforementioned events was unknown. The reporter did not assess the causal relationship between therapy with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) and the events.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Malaise
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Immunisation
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1788944

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

mild
Staat
CA
Alter
73,0
Geschlecht
M
Eingang
15.10.2021
Impfdatum
13.10.2021
Beginn
13.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Pain in extremity Peripheral swelling

Symptomtext

His whole arm got extensively painful and swollen the night following the injection and still not resolved. Patient is referred to see a doctor.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2607826

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

gering
Staat
-
Alter
-
Geschlecht
U
Eingang
01.04.2023
Impfdatum
29.03.2023
Beginn
29.03.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

No AE ocurred; An expired dose was administered to a patient; This spontaneous report was received from a consumer referring to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not provided. Concomitant therapies were not reported. On 29-MAR-2023, the patient was vaccinated with an expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, at a dose of 0.5 milliliters (lot #U018309 with an expiration date on 08-JAN-2023), administered for prophylaxis (strength, and route of administration were not provided) (expired product administered). No adverse event occurred.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2607824

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

gering
Staat
FL
Alter
-
Geschlecht
U
Eingang
01.04.2023
Impfdatum
28.03.2023
Beginn
28.03.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE reported; Product expired 1/8/2023 and was administered to 2 patients today 3/28/2023. Product had not experienced any temperature excursions through the date of administration; This spontaneous report has been received from a pharmacist, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications, previous drug reactions, and allergies were not provided. On 28-MAR-2023, the patient was vaccinated with an expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection as prophylaxis (lot number U018309 has been verified to be valid; expiration date reported an established as 08-JAN-2023) (expired product administered) (strength, dose, route of administration, and anatomical location were not provided). No additional adverse events were reported. This is one of two reports received from the same reporter. ; Sender's Comments: US-009507513-2303USA010031:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2606948

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

gering
Staat
FL
Alter
-
Geschlecht
U
Eingang
31.03.2023
Impfdatum
28.03.2023
Beginn
28.03.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE reported; Pharmacist reports expired PNEUMOVAX 23 was administered to 2 patients. Product expired 1/8/2023 and was administered to 2 patients today 3/28/2023. Product had not experienced any temperature excursions through the date of administration. See additi; This spontaneous report has been received from a pharmacist, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications, previous drug reactions, and allergies were not provided. On 28-MAR-2023, the patient was vaccinated with an expired dose of Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23) injection as prophylaxis (lot number U018309 has been verified to be valid; expiration date reported an established as 08-JAN-2023) (expired product administered) (strength, dose, route of administration, and anatomical location were not provided). No additional adverse events were reported. This is one of two reports received from the same reporter. ; Sender's Comments: US-009507513-2303USA010066:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2590764

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

gering
Staat
WA
Alter
-
Geschlecht
U
Eingang
03.03.2023
Impfdatum
08.02.2023
Beginn
08.02.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AEs; The nurse reported that a dose of PNEUMOVAX 23 that was expired was administered to a patient. No additional AE's and no PQC's were reported.; This spontaneous report was received from licensed practical nurse and refers to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant medication, and drug reactions or allergies were not reported. On 08-FEB-2023, the patient was vaccinated with expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23), 1 dosage form (reported as product quantity: 1), lot # U018309, expiration date: 08-JAN-2023, administered as directed to prevent pneumococcal infection (strength, route of administration, and anatomical location were not provided) (expired product administered). No additional adverse events were reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2586593

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

gering
Staat
NY
Alter
8,0
Geschlecht
F
Eingang
24.02.2023
Impfdatum
15.02.2023
Beginn
15.02.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; Pharmacist reports patient was accidently administered an expired dose of PNEUMOVAX 23 on Feb 15, 2023.; This spontaneous report was received from a pharmacist and refers to an 8-year-old female patient. There was no information regarding the patient's medical history, concurrent condition and concomitant therapies details. On 15-FEB-2023, the patient was accidently vaccinated with an expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, once, lot #U018309, expiration date: 08-JAN-2023, administered for prophylaxis (strength, and route of administration were not provided) (Expired product administered). Product had no prior temperature excursions. No further information provided. No additional adverse event or product quality complaint was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2585867

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

gering
Staat
VA
Alter
-
Geschlecht
U
Eingang
23.02.2023
Impfdatum
14.02.2023
Beginn
14.02.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No symptomatic side effects reported; a patient was inadvertently administered and expired PNEUMOVAX 23; This spontaneous report was received from other and refers to a patient of an unknown age and gender. The patient's pertinent medical history, concurrent conditions, previous drug reactions or allergies, and concomitant therapies were not reported. On 14-FEB-2023, the patient was inadvertently administered with an expired pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, lot # U018309, expiration date: 08-JAN-2023, administered for prophylaxis (strength, dose and route of administration were not provided). No symptomatic side effects or prior temperature excursion were reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2578490

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

gering
Staat
OH
Alter
-
Geschlecht
U
Eingang
09.02.2023
Impfdatum
16.01.2023
Beginn
16.01.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; SRP Voicemail received on 16JAN2023 at 8:56am reporting that PNEUMOVAX 23 expired on 08JAN2023 and was administered on 16JAN2023. Company awareness date reflects the date the voicemail was received. Filing today as it was outside of business hours. N; This spontaneous report was received from a nurse, and refers to a patient of unknown age and gender. No information was reported regarding the patient's medical history, concurrent conditions or concomitant medications. On 16-JAN-2023, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) prefilled syringe, lot number U018309, for prophylaxis (route of administration was unknown). The dose of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) that was administered to the patient had expired on 08-JAN-2023. There was no temperature excursions. No adverse event were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2576032

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

gering
Staat
OR
Alter
-
Geschlecht
U
Eingang
06.02.2023
Impfdatum
-
Beginn
01.01.2023
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event Product storage error

Symptomtext

no additional AE's were reported.; patient that was administered to a patient after it expired.; the product also had a previous temperature excursion.; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, drug allergies, reactions, or concomitant medications was not provided. On 30-JAN-2023, the patient was vaccinated with an expired and improperly stored dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23 SYRINGE (DEVICE)) injection (lot #U018309 had been verified to be a valid number; expiration date 08-JAN-2023, and upon internal validation established as the same date) for prophylaxis (dosage, vaccination scheme, frequency, route of administration, and anatomical site of injection were not reported). The administered dose of the vaccine was stored at an unknown temperature for an unknown time frame. There was not previous temperature excursion reported. There was no adverse effect reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2570714

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

gering
Staat
OR
Alter
71,0
Geschlecht
F
Eingang
30.01.2023
Impfdatum
30.01.2023
Beginn
30.01.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Pt in need of Pneumovax vaccine, LN inadvertently administered Expired Immunization. LN informed PCP of inadvertent vaccine administration and clinical/medical director, LN called Merck& Co in and spoke with medial staff in regards to inadvertent vaccine administration staff stated they would call this LN in 1 business day with more information on inadvertent vaccine administration.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Chronic systolic congestive heart failure Chronic gout without tophus Obesity Lumbosacral spondylosis without myelopathy Edema, unspecified Essential (primary) hypertension Hyperlipidemia, unspecified Irritable bowel syndrome Osteoarthritis of both knees Overactive bladder Spinal stenosis, lumbar region, without neurogenic claudication Venous stasis Unsteadiness on feet Chronic kidney disease, stage 3 unspecified Other chronic pain
Andere Medikamente
CHEWABLE MULTI VITAMIN ORAL acetaminophen (TYLENOL) 500 mg tablet aspirin 81 mg DR tablet atorvastatin (LIPITOR) 40 mg tablet cyclobenzaprine (FLEXERIL) 5 mg tablet DULoxetine (CYMBALTA) 60 mg DR capsule ferrous sulfate 325 mg (65 mg iron)
Allergien
Moexipril Moexipril Palpitations Medium Intolerance 7/20/2018 Deletion Reason: Opioids - Morphine Analogues Opioids - Morphine Analogues Nausea and Vomiting, Rash Medium Intolerance 4/15/2000 sick sick Deletion Reason: Sulfa (Sulfonamide Antibiotics) Sulfa (Sulfonamide Antibiotics) Rash Medium Not Verified 7/20/2018 Other reaction(s): Cutaneous reactions Deletion Reason: Codeine
Vorherige Impfungen
-

VAERS 2568183

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

gering
Staat
OH
Alter
-
Geschlecht
U
Eingang
26.01.2023
Impfdatum
18.01.2023
Beginn
18.01.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; An HCP is reporting an AE on behalf of a patient. The HCP reports that the patient was administered a dose of PNEUMOVAX 23 after it expired. No additional AE details were provided and no additional AE's were reported. No PQC.; This spontaneous report has been received from pharmacist and refers to an identified patient of unknown age and gender. Information regarding the patient's medical history, concurrent conditions, concomitant therapies, and past drug allergies or drug reactions were not provided. On 18-JAN-2023, the patient was vaccinated with an expired pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) syringe injection, 0.5 milliliter (mL) (lot #U018309 confirmed to be valid, expiration date reported and stablished as 08-JAN-2023) administered intramuscularly for prophylaxis (strength was not provided) (expired product administered). No additional adverse event (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2567150

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

gering
Staat
WA
Alter
-
Geschlecht
M
Eingang
25.01.2023
Impfdatum
20.01.2023
Beginn
20.01.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AEs; expired lot of PNEUMOVAX 23 / lot expired on 1/8/23 and vaccine was administered on 1/20/23; This spontaneous report was received from a Medical Assistant and refers to a 75 year old male patient. Information regarding the patient's concurrent conditions, pertinent medial history and concomitant medications was not provided. On 20-JAN-2023, the patient was vaccinated with an expired dose of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23), (Lot # U018309, expiration date 08-JAN-2023), dosage 0.5 ml once, route of administration and anatomical location were not reported for prophylaxis. No additional adverse events, no product quality complaint (PQC) were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2328461

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

gering
Staat
AZ
Alter
1,3
Geschlecht
M
Eingang
22.06.2022
Impfdatum
21.06.2022
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Wrong product administered

Symptomtext

Wrong vaccine given to patient

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2254584

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

gering
Staat
OH
Alter
67,0
Geschlecht
M
Eingang
27.04.2022
Impfdatum
25.04.2022
Beginn
25.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Vaccination error

Symptomtext

Patient was given a pneuomvax 23 with out an order and when it was not needed. Patient had previously received the prevnar 12 in 2019 and the pneumovax 23 in 2020. No harm was done to the patient.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
n/a
Vorgeschichte
Coronary arteriosclerosis, Hypertension, GERD, hyyperlipidemia, anemia
Andere Medikamente
Amlodipine 5mg, Esomeprazole 20mg, Ezetimibe 10mg, Metoprolol succ 25mg, Multivitamin
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 2237184

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

gering
Staat
WA
Alter
-
Geschlecht
U
Eingang
16.04.2022
Impfdatum
22.12.2021
Beginn
22.12.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No further adverse events; Doses administered during temperature excursion; This spontaneous report was received from a office manager (who was a clinical manager and also a medical assistant) and refers to a patient of unknown age and gender. Information about medical history, concurrent conditions and concomitant therapies was not provided. On 22-DEC-2021, improperly stored pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) syringe (lot#U018309 and expiration date:08-JAN-2023) (dose, route of administration and anatomical location were not provided) was administered to the patient for prophylaxis (product storage error). No additional adverse event was reported. This is one of three reports received from the same reporter. ; Sender's Comments: US-009507513-2203USA007589: US-009507513-2204USA004696:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2237182

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

gering
Staat
WA
Alter
-
Geschlecht
U
Eingang
16.04.2022
Impfdatum
18.03.2022
Beginn
18.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No further adverse events; Doses administered during temperature excursion; This spontaneous report was received from a office manager (who was a clinical manager and also a medical assistant) and refers to a patient of unknown age and gender. Information about medical history, concurrent conditions and concomitant therapies was not provided. On 18-MAR-2022, improperly stored pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) syringe (lot#U018309 and expiration date:08-JAN-2023) (dose, route of administration and anatomical location were not provided) was administered to the patient for prophylaxis (product storage error). No additional adverse event was reported. This is one of three reports received from the same reporter. ; Sender's Comments: US-009507513-2203USA007589: US-009507513-2204USA005263:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2225121

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

gering
Staat
MI
Alter
-
Geschlecht
F
Eingang
09.04.2022
Impfdatum
30.03.2022
Beginn
30.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Syringe issue Underdose

Symptomtext

a patient may have received less than the recommended dose of PNEUMOVAX 23 due to difficullty pushing the prefilled syringe rod; PNEUMOVAX 23 reorted the syringe plunger felt like it was "sticky" as if it were stuck; This spontaneous report as received from a nurse, concerning a female patient of unknown age. The patient's concurrent conditions, medical history and concomitant medication were not reported. On 30-MAR-2022, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) (lot # U018309 has been verified to be valid, expiration date not reported, but upon internal validation established as 08-JAN-2023) (anatomical location not reported) for prophylaxis. Moreover, the nurse explained that the patient may have received less than the recommended dose (incorrect dose administered) of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) due to difficulty pushing the prefilled syringe rod (syringue issue). Caller said, the health care professional (HCP) who administered the pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) reported the syringe plunger felt like it was "sticky" as if it were stuck. Caller said the HCP who was administering the pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) withdrew the needle and re-stuck the patient to attempt to administer the remaining medication. Caller said upon withdrawal of the needle, there appeared to be some pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) remaining in the syringe. Caller explained since she was not the HCP who administered the medication, she was unable to provide any further clarifying details. Caller declined replacement of the product. Caller was unable to provided photos or return the product because it was already discarded.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syringe issue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2118370

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

gering
Staat
WV
Alter
-
Geschlecht
U
Eingang
17.02.2022
Impfdatum
08.02.2022
Beginn
08.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No other issues or concerns noted; Improperly sorted PNUEMOV AX 23 administered 2/8/2022; This spontaneous report was received from a nurse referring to a patient of unknown age and unknown gender. Information about pertinent medical history, concurrent condition, concomitant medication and drug reaction/allergy was not provided. On 08-FEB-2022, the patient was vaccinated with improperly sorted (previous temperature excursion was 15.7 degrees Celsius for 8 hours, 10 degrees Celsius for 6 hours) pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (lot # U018309 with expiration date 08-JAN-2023; strength, dose, frequency and route were not reported) for prophylaxis (product storage error). No other issues or concerns noted. The outcome of product storage error was unknown.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1961051

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

gering
Staat
-
Alter
-
Geschlecht
U
Eingang
18.12.2021
Impfdatum
-
Beginn
18.11.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No additional AE's or PQC's were reported; improperly stored dose of Pneumovax was administered to a patient; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. No information regarding the patient's concurrent conditions, medical history, drug reactions or allergies and concomitant medications was provided. On 18-NOV-2021, the patient was vaccinated with first dose of improperly stored (temperature excursion occured on 04-NOV-2021) pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) lot# U018309, expiration date: 08-JAN-2023 (exact dose, route of administration, anatomical location were not reported) for prophylaxis. Administered dose of vaccine has been stored in the temperature of 70 Fahrenheit (F) for 16 hours. There were no previous temperature excursions reported. No adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1954049

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

gering
Staat
IN
Alter
-
Geschlecht
U
Eingang
16.12.2021
Impfdatum
02.12.2021
Beginn
02.12.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Wrong product administered

Symptomtext

no adverse event; patient at the office today, 12/2/2021, who was scheduled to receive GARDASIL 9. The patient inadvertently received a dose of PNEUMOV AX 23 instead of GARDASIL 9.; patient at the office today, 12/2/2021, who was scheduled to receive GARDASIL 9. The patient inadvertently received a dose of PNEUMOV AX 23 instead of GARDASIL 9; patient at the office today, 12/2/2021, who was scheduled to receive GARDASIL 9. The patient inadvertently received a dose of PNEUMOV AX 23 instead of GARDASIL 9; Information has been received from the office manager, referring to a 11 years-old male patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 02-DEC-2021, the patient was scheduled to receive hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9), however, instead of this vaccine the patient inadvertently received a dose of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) lot # U018309, expiration date 08-JAN-2023 (anatomical location and administration route were not reported) for prophylaxis. The reporter stated that the patient missed his second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9), but the patient did receive a flu shot (manufacturer unknown) also on 02-DEC-2021. No additional adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1889594

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

gering
Staat
WA
Alter
55,0
Geschlecht
M
Eingang
22.11.2021
Impfdatum
19.11.2021
Beginn
19.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered Wrong product administered

Symptomtext

Patient received a 2nd flu this season by mistake when patient was supposed to receive Tdap and Pneumovax.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
type 2 diabetes hyperlipidemia
Andere Medikamente
tylenol, melatonin, flonase, vitamin D
Allergien
Clomipramine
Vorherige Impfungen
-

VAERS 1768760

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U018309

gering
Staat
CA
Alter
54,0
Geschlecht
M
Eingang
07.10.2021
Impfdatum
06.10.2021
Beginn
06.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Wrong product administered

Symptomtext

Patient was given a Tdap instead of a Hep B vaccine. Notified and consulted with doctor and clinic supervisor. No adverse effect to patient. No treatment needed. Notified patient.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
NA
Vorgeschichte
Type 2 diabetes mellitus w/ hyperosmolarity w/out come, w/out long-term current use of insulin. Anxiety. Chronic upper back pain.
Andere Medikamente
Ciclopirox 8% Solution, Zoloft 25mg, MetFORMIN 500mg, Polyethylene Glycol 17mg packet.
Allergien
NA
Vorherige Impfungen
-